Full-Time

Scientist – Msat

Confirmed live in the last 24 hours

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid, Senior

Somerset County, NJ, USA

Category
Computational Biology
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor's or master's degree in Biochemistry, Biotechnology, Chemical Engineering, or a related field
  • 2-5 years of experience in MS&T, process development, or a related field
  • Strong understanding of cell therapy, automation, and bioprocessing principles
  • Excellent communication and project management skills
  • Ability to work effectively in a fast-paced, dynamic environment
  • Knowledge of automation technologies and GMP practices is a plus
  • Experience in analytical assays such as flow cytometry, qPCR, ELISA, and other assays is highly desired
  • Experience with CAR-T cell therapy or similar cellular therapy products
  • Familiarity with design of experiments (DOE) and statistical process control (SPC)
  • Experience with data analytics and visualization tools
Responsibilities
  • Assist in designing and executing process development experiments
  • Author and review technical documents, protocols, and reports
  • Analyze and present data in a clear and concise manner
  • Ensure GMP compliance in laboratory notebooks, protocols, and reports
  • Collaborate with internal and external partners to evaluate and implement new process technologies
  • Support technology transfer activities to ensure successful implementation of new processes or technologies in GMP manufacturing environments
  • Assist in implementing automation technologies to enhance process efficiency and productivity
  • Collaborate with cross-functional teams to ensure successful implementation of GMP practices and procedures
  • Perform and interpret analytical assays such as flow cytometry, qPCR, ELISA, and other assays to support process development and optimization

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

15%

1 year growth

40%

2 year growth

102%
Simplify Jobs

Simplify's Take

What believers are saying

  • CARVYKTI® received FDA and European Commission approval for expanded use in multiple myeloma.
  • Legend Biotech is expanding R&D with a new facility in Philadelphia.
  • Collaboration with Multiply Labs aims to automate and improve cell therapy manufacturing.

What critics are saying

  • Increased competition from Amgen's Imdelltra could impact Legend's market share.
  • Expansion into new R&D facilities may strain financial resources.
  • Dependency on external technology through partnerships like MaxCyte could pose risks.

What makes Legend Biotech unique

  • Legend Biotech focuses on personalized cell therapies for hard-to-treat cancers.
  • The company is technology agnostic, exploring multiple platforms for effective treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line treatment.

Help us improve and share your feedback! Did you find this helpful?